SNTI
Senti Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$26.54M
P/E Ratio
—
EPS
$-2.71
Beta
2.12
52W High
$5.10
52W Low
$0.77
50-Day MA
$0.93
200-Day MA
$1.49
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Senti Biosciences Inc
Senti Biosciences Inc (SNTI) is a cutting-edge biotechnology company focused on revolutionizing synthetic biology to develop next-generation cell and gene therapies. Leveraging its proprietary GeneCircuit platform, Senti aims to create programmable therapies designed to address a variety of diseases, including cancer and genetic disorders, thus enhancing the precision of personalized medicine. With a strong development pipeline and strategic partnerships, Senti is well-positioned to lead advancements in engineered cell therapies, providing innovative solutions to address significant unmet medical needs in the biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 22,000 |
| Gross Profit (TTM) | $-37.56M |
| EBITDA | $-54.67M |
| Operating Margin | -37095.00% |
| Return on Equity | -218.10% |
| Return on Assets | -48.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.18 |
| Price-to-Book | 4.84 |
| Price-to-Sales (TTM) | 1206.28 |
| EV/Revenue | 1795.94 |
| EV/EBITDA | -0.28 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $31.14M |
| Float | $14.58M |
| % Insiders | 47.60% |
| % Institutions | 18.45% |
Historical Volatility
HV 10-Day
83.00%
HV 20-Day
72.42%
HV 30-Day
63.07%
HV 60-Day
70.68%
HV Rank
—
Volatility is currently expanding
Data last updated: 4/9/2026